These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


Pubmed for Handhelds

PUBMED FOR HANDHELDS

Journal Abstract Search

175 related items for PubMed ID: 16813911

  • 1.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 2. Effectiveness of intravesical resiniferatoxin for anticholinergic treatment refractory detrusor overactivity due to nonspinal cord lesions.
    Kuo HC.
    J Urol; 2003 Sep; 170(3):835-9. PubMed ID: 12913711
    [Abstract] [Full Text] [Related]

  • 3. Multiple intravesical instillation of low-dose resiniferatoxin is effective in the treatment of detrusor overactivity refractory to anticholinergics.
    Kuo HC.
    BJU Int; 2005 May; 95(7):1023-7. PubMed ID: 15839924
    [Abstract] [Full Text] [Related]

  • 4. Urodynamic effect of intravesical resiniferatoxin in patients with neurogenic detrusor overactivity of spinal origin: results of a double-blind randomized placebo-controlled trial.
    Silva C, Silva J, Ribeiro MJ, Avelino A, Cruz F.
    Eur Urol; 2005 Oct; 48(4):650-5. PubMed ID: 15961217
    [Abstract] [Full Text] [Related]

  • 5.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 6. Intravesical resiniferatoxin versus botulinum-A toxin injections for neurogenic detrusor overactivity: a prospective randomized study.
    Giannantoni A, Di Stasi SM, Stephen RL, Bini V, Costantini E, Porena M.
    J Urol; 2004 Jul; 172(1):240-3. PubMed ID: 15201783
    [Abstract] [Full Text] [Related]

  • 7.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 8. Multiple intravesical instillations of low-dose resiniferatoxin in the treatment of refractory interstitial cystitis.
    Peng CH, Kuo HC.
    Urol Int; 2007 Jul; 78(1):78-81. PubMed ID: 17192738
    [Abstract] [Full Text] [Related]

  • 9.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 10.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 11.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 12. Intravesical vanilloids and neurogenic incontinence: ten years experience.
    Lazzeri M, Spinelli M, Zanollo A, Turini D.
    Urol Int; 2004 Jul; 72(2):145-9. PubMed ID: 14963356
    [Abstract] [Full Text] [Related]

  • 13. Intravesical capsaicin versus resiniferatoxin for the treatment of detrusor hyperreflexia in spinal cord injured patients: a double-blind, randomized, controlled study.
    de Sèze M, Wiart L, de Sèze MP, Soyeur L, Dosque JP, Blajezewski S, Moore N, Brochet B, Mazaux JM, Barat M, Joseph PA.
    J Urol; 2004 Jan; 171(1):251-5. PubMed ID: 14665887
    [Abstract] [Full Text] [Related]

  • 14. The effect of intravesical resiniferatoxin in patients with idiopathic detrusor instability suggests that involuntary detrusor contractions are triggered by C-fiber input.
    Silva C, Ribeiro MJ, Cruz F.
    J Urol; 2002 Aug; 168(2):575-9. PubMed ID: 12131313
    [Abstract] [Full Text] [Related]

  • 15. Role of C afferent fibers and monitoring of intravesical resiniferatoxin therapy for patients with idiopathic detrusor overactivity.
    Yokoyama T, Nozaki K, Fujita O, Nose H, Inoue M, Kumon H.
    J Urol; 2004 Aug; 172(2):596-600. PubMed ID: 15247740
    [Abstract] [Full Text] [Related]

  • 16.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 17.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 18. Effects of tolterodine on afferent neurotransmission in normal and resiniferatoxin treated conscious rats.
    Hedlund P, Streng T, Lee T, Andersson KE.
    J Urol; 2007 Jul; 178(1):326-31. PubMed ID: 17507042
    [Abstract] [Full Text] [Related]

  • 19.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 20.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

    Page: [Next] [New Search]
    of 9.